Abnormalities were most frequent in the SCN2A (70.6%) group, followed by the SCN8A (42.9%) and SCN1A (31.6%) groups; one patient with SCN3A-related epilepsy also exhibited abnormal findings. This evidence concerns the gene SCN1A and epilepsy.